RTW Biotech Opportunities (LON:RTW – Get Free Report) rose 1.5% in intraday trading on Thursday. The stock traded at a high of GBX 1.37 ($0.02) and last traded at GBX 1.37 ($0.02). 28,823 shares were traded during the session, -96% decrease from the average session volume of 738,808 shares. The stock previously closed at GBX 1.35 ($0.02).
RTW Biotech Trading Opportunities Up 1.5%
The stock's 50-day simple moving average is GBX 1.32 and its 200-day simple moving average is GBX 1.29. The company has a market capitalization of 5.27 million pounds, a price-to-earnings ratio of 3.81x, and a beta of 0.60x.
RTW Biotechnology Opportunities Company Profile
(Get Free Report)
RTW Biotech Opportunities Ltd is a venture capital fund. This fund specializes in direct investments and early stage investments. The fund specializes in identifying innovative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation treatments and technologies that can significantly improve the lives of patients.
Featured articles
Receive daily RTW biotech opportunity news and reviews – Enter your email address below to receive a concise, daily summary of the latest news and analyst ratings on RTW Biotech Opportunities and related companies in MarketBeat.com's free daily email newsletter.
